MHLW Japan Approves 14 New Drugs For NHI Listing
This article was originally published in PharmAsia News
Executive Summary
Fourteen new drugs were selected for NHI listing by the Japanese Central Social Insurance Medical Council on May 14, with actual listing planned for May 23.